76
Participants
Start Date
December 5, 2024
Primary Completion Date
June 5, 2025
Study Completion Date
June 5, 2025
Melatonin
Participants in this group will receive 6 mg of melatonin orally, administered as two 3 mg tablets 30 minutes before bedtime daily for 8 weeks, alongside their standard antipsychotic treatment (risperidone 6-8 mg/day).
Placebo
Participants in this group will receive placebo tablets identical in shape, size, smell, taste, and color to melatonin tablets, administered in the same manner (two tablets 30 minutes before bedtime) for 8 weeks, alongside their standard antipsychotic treatment (risperidone 6-8 mg/day).
Lahore General Hospital, Lahore, Lahore
Lahore General Hospital
OTHER_GOV